Cargando…
Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
Background. MicroRNA-33a and -b (miR-33a/b) have been revealed to be posttranscriptional regulators of HDL metabolism. Xuezhikang (XZK) is a marked natural HDL-raising polypill. We aim to evaluate the effects of XZK on the expression of circulating miR-33a/b in patients with low plasma HDL-C levels....
Autores principales: | Cao, Ruihua, Bai, Yongyi, Sun, Lan, Zheng, Jin, Zu, Mian, Du, Guanhua, Ye, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925606/ https://www.ncbi.nlm.nih.gov/pubmed/24591767 http://dx.doi.org/10.1155/2014/781780 |
Ejemplares similares
-
Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021) -
Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study
por: Zheng, J., et al.
Publicado: (2017) -
Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides
por: Rayner, Katey J., et al.
Publicado: (2011) -
Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
por: Zhu, Li-Yuan, et al.
Publicado: (2021) -
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017)